The below is an excerpt from my book, Stem Cells: An Insider’s Guide. I hope you enjoy this excerpt and the book, which I think is a really good deal at under $27 paperback or under $17 for E-book version. Having our innovation and ethics too In the stem cell field you can have it […]
Book Excerpt: Stem Cell For-Profit Good Citizen Biotechs Read More »
There was a Twitter buzz yesterday about a Science news story on Korean cloning fraud Woo Suk Hwang’s efforts for redemption in the scientific community. What was the big deal? It turns out to be a peculiar situation. The Science Hwang piece by Dennis Normile, entitled “After Fraud, Korean Cloner Seeks Redemption”, was eerily similar in
Did Clone-Like Nature & Science Pieces Boost Hwang Redemption PR Effort? Read More »
In the interview below I talk with Dr. Masayo Takahashi, who is leading a team conducting the first ever in-human clinical study based on iPS cells. The work began with patient enrollment on Aug. 1, 2013 in Japan. Masaya Takahashi background 1. Can you tell us a bit about your background? As an M.D./Ph.D. and
Masayo Takahashi Interview on iPS cells, clinical studies, & more Read More »
One of the most concerning new trends in the stem cell arena is the explosive growth of chains of for-profit stem cell clinics in the US including Stem MD. This kind of franchising of stem cell for-profit operations deeply concerns me in terms of its potential risks to increasing numbers of patients and to the
Claims of Stem Cell Cures by Clinic Chain, Stem MD Read More »
Reading these one doesn’t know whether to laugh or cry they are so stupid. “Top researcher: iPS cells ‘probably’ already embryos”. This article was so wrong about so many things that it gives dumb a bad name. “‘Adventurous’ woman sought to carry Neanderthal baby”. Who needs the National Enquirer? “Dana White media scrum: Meniere’s disease cured by
Dumbest stem cell headlines & stories of 2013 Read More »
There have been many interesting developments in stem cells in 2013, but to me the biggest event by far was the first ever successful somatic cell nuclear transfer (SCNT)-based human therapeutic cloning. This approach generated apparently genetically normal human embryonic stem cells (hESC), an astonishing accomplishment. There are two kinds of human cloning: therapeutic and reproductive.
Stem cell story of the year: human therapeutic cloning Read More »
Remember the Texas stem cell clinic Celltex, most famous for treating Texas Governor Rick Perry? Celltex had a busy few years, but has been relatively under the radar for most of 2013. Does that mean it’s gone? Hardly. Their saga became more serious when the FDA sent it a warning letter that was predicted by this
Saga of Texas Stem Cell Clinic Celltex Continues Read More »
By Jeanne Loring “Shared Labs Axed” was the headline for David Jensen’s blog about the California Institute for Regenerative Medicine, the funding agency founded after voters approved Proposition 71, the “stem cell research and cures” initiative. I was there when the ax fell, in Los Angeles at the meeting of CIRM’s governing board, along with
Guest Post By Jeanne Loring: Efforts to Save CIRM Shared Labs Read More »
The World Stem Cell Summit in San Diego was a great meeting this past week. It was my 3rd straight Summit and the best of all. It’s a unique mix of science, medicine, and policy that links together key players from every corner of the field. I talked stem cells one-on-one or in small groups
Key Questions for the Stem Cell Field for 2014 Read More »
I just participated in a panel discussion at the World Stem Cell Summit moderated by Lee Buckler on what patients should be thinking about as they contemplate non-compliant stem cell interventions. Also on the panel was Dr. Allan Wu. Both Lee and Al are exceptional members of the stem cell community so it was fantastic
World Stem Cell Summit Panel on Non-Compliant Stem Cells Read More »